You are in:Home/Publications/Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children

Dr. sameh elsayed zaki abdulsamea :: Publications:

Title:
Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children
Authors: Abdulsamea S1, Anderson P, Biassoni L, Brennan E, McLaren CA, Marks SD, Roebuck DJ, Selim S, Tullus K
Year: 2010
Keywords: Not Available
Journal: Pediatric Nephrology
Volume: 25
Issue: 2
Pages: 317-22
Publisher: Springer Berlin Heidelberg
Local/International: International
Paper Link:
Full paper samehelsayed zaki abdabdelsamie_art%3A10.1007%2Fs00467-009-1304-9.pdf
Supplementary materials Not Available
Abstract:

We studied the ability of pre- and postcaptopril renal scintigraphy to predict renovascular disease (RVD) in children. Retrospective review of medical notes and radiology reports of all hypertensive children who had had both pre- and postcaptopril renal scintigraphy with [(99m)Tc] dimercaptosuccinic acid (DMSA) and/or [(99m)Tc] mercaptoacetyltriglycine (MAG3) and digital subtraction angiography (DSA). 81 children aged 1-18 (median 10) years were studied with 62% (51) having a diagnosis of RVD. Main renal artery disease, intrarenal disease, and both main and intrarenal artery disease were present in 25, 14, and 12 patients respectively. The isotope study accurately diagnosed RVD, confirmed by DSA, in 47% (24 of 51) children, with eight false positive studies. The sensitivity, specificity, and positive and negative predictive values of the isotope study to predict RVD were 48%, 73%, 76%, and 51%, respectively. Pre- and postcaptopril renal scintigraphy was unable to predict RVD in children

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus